PBS means Australian patients and government are paying less for products

29 October 2014
australia-big

Australian patients continue to pay less for medicines due to a notable rise in the number of prescriptions costing less than the Pharmaceutical Benefit Scheme (PBS) co-payment, according to a report released this week.

The PBS Expenditure and Prescriptions Twelve Months to 30 June 2014 report confirms that the cost to fill a prescription is not only dropping for patients, but for the Australian government as well.

The total expenditure under the PBS was confirmed to have risen by only A$152 million to A$9.15 billion ($8.13 billion), which is well below the rate of inflation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical